FY 2001 OHIP Annual Report - From the Director
The Office of Health and Industry Programs (OHIP) provides services that directly affect the lives of millions of Americans. As one of the Offices within the Center for Devices and Radiological Health (CDRH), U.S. Food and Drug Administration (FDA), we specialize in program-based communication, education, radiological health, mammography quality, and reduction of use error.
Outreach and education are in all aspects of OHIP’s work. This is evident whether we are producing teleconferences, training CDRH staff, working with patients/consumers/health professionals, assuring high quality mammography, conducting radiation safety surveys, answering device industry questions, or writing regulations. As we carry out our programs, we emphasize collaboration both within and outside CDRH. Coalition building, public participation, and information exchange allow us to obtain input from all relevant and concerned sources and to leverage and multiply our resources to protect the public health.
Because of the breadth of our role within CDRH, OHIP serves a wide variety of customers, including:
We think that each of our customers will find programs of interest in our FY2001 Annual Report. We think our programs and our accomplishments reflect changes and improvements implemented as a result of OHIP strategic planning. In 1997, OHIP implemented an ambitious five-year strategic plan.
As a first step, we received specific feedback from our customers in all of our program areas. While our customers were generally satisfied with our services, we received many suggestions and comments for changes and improvements. In response to this feedback, OHIP developed four specific goals:
OHIP is now in the fifth and final year of our strategic planning process. As reflected in our Annual Report, OHIP’s four goals are now tightly integrated into our programs and daily operations. During the coming year, we will continue to update and refine our strategic plan and concentrate our efforts on the CDRH strategic plan. As the plan is implemented, it will provide broad principles and goals that CDRH will commit itself to over the next several years.
Our work is guided by the CDRH mission and vision. Mission: to promote and protect the health of the public by ensuring the safety and effectiveness of medical devices and the safety of radiological products. Vision: "Ensuring the health of the public throughout the Total Product Life Cycle."
|During this past year, OHIP has worked toward the CDRH mission, vision and strategic goals. These goals include the following:
OHIP continues to work with all of CDRH to implement these strategic goals. We co-lead the magnet for excellence goal group and we lead outreach efforts inherent in all four goal groups. Together with you, our stakeholders, we are preparing a roadmap for the future of OHIP and for CDRH. For more detailed information on the CDRH strategic plan, visit the CDRH website at http://www.fda.gov/cdrh/ocd/strategic.html.
We welcome your review of OHIP’s FY2001 Annual Report and your comments on our programs and future directions.